A common food source has been converted into a biomanufacturing platform that enables mass production of biologic drugs for common diseases that currently lack effective treatments....
Therapeutic bacteria can now ‘hide’ from being hunted down by immune systems, thanks to pioneering work performed at Columbia University in the US. Researchers report that...
Spanish biotech KeyZell is aiming for €5m in funding to conduct a human clinical trial for its novel brain cancer treatment. Based on company founder Dr.Nabil Hajji’s...
Genflow Biosciences has received a research grant award of up to €3.375m from the regional government of Wallonia in southern Belgium. Genflow, a UK-based biotechnology, is focused...
The study included bacteria from wound and UTI infections
Biotech firm SpliceBio, which is exploiting protein splicing to develop the next generation of gene therapies, has completed a £42m fundraise. Adeno-associated viruses (AAV) are the...
Dxcover, developer of liquid biopsies for the early detection of cancer, has secured US patents for its groundbreaking Dxcover Autosampler and the Dxcover Brain Cancer Liquid...
Ovid Therapeutics, a biopharma firm focused on neurological diseases, and Healx, the AI-based drug discovery company, have signed a commercial partnership. Healx has secured from Ovid...
A cloud-based repository that creates a digital fingerprint of engineered microorganisms has been successfully trialled. An international team led by Newcastle University has launched CellRepo, a species...
Researchers at the universities of Linköping in Sweden and Okayama in Japan have developed microrobots that can morph into various shapes before hardening. Edwin Jager, associate...
